Stay updated on TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial
Sign up to get notified when there's something new on the TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial page.

Latest updates to the TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial page
- Check4 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.8%
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check26 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check54 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check68 days agoChange DetectedThe web page has undergone significant updates, including the addition of a new study on the efficacy and safety of Tyrosine Kinase Inhibitors in combination with anti-PD-1 antibodies for treating MSS/pMMR metastatic colorectal adenocarcinoma, along with a revision update to v2.15.0. Notably, the previous detailed description of the study's purpose and methodology has been removed.SummaryDifference42%
- Check76 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial page.